30,188 Followers on Owler
OverviewCompetitorsAcquisitionsInvestmentsNews & Insights

Sanofi Acquisitions

Sanofi has acquired 19 companies and its latest acquisition was Inhibrx, Inc. on Jan 2024

Unlock 16 more acquisitions →
COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
Inhibrx, Inc.

Jan 2024

Source »
$1.7B
InhibRx is a California-based clinical-stage biopharmaceutical company that researches and develops novel therapeutics for the treatment of cancer.
Qunol

Jul 2023

Source »
undisclosed
Qunol is a New Jersey-based health and wellness company that manufactures and retails products such as turmeric and dietary supplements and vitamin tablets for individuals.
Provention Bio, Inc.

Mar 2023

Source »
$2.9B
Provention Bio is a New Jersey-based biopharmaceutical company that researches and develops novel therapeutics for the treatment of autoimmune diseases.
Amunix Pharmaceuticals, Inc.

Dec 2021

Source »
$1B
Amunix is a California-based biotechnology company that develops and markets T-cell and cytokine therapies for the treatment of cancer.
Origimm Biotechnology GmbH

Dec 2021

Source »
undisclosed
Origimm is an Austria-based biotechnology company that develops and commercializes antigens and functional drug targets for the treatment of skin diseases.

Frequently Asked Questions about Sanofi

  1. What companies did Sanofi acquire?

    Companies acquired by Sanofi include Inhibrx, Qunol and Provention Bio

  2. How many acquisitions does Sanofi have?

    Sanofi has acquired 19 companies including Inhibrx, Qunol and Provention Bio.

  1. How many acquisitions did Sanofi make in 2024?

    In 2024 Sanofi acquired 1 companies including Inhibrx.